NuProbe Global to Commercialize Multiplexed, Rare Gene Testing Technology
Harvard’s Wyss Institute researchers are bringing a specific and multiplexed genetic diagnostic technology to market with NuProbe Global, a Boston based company. It addresses the current need to detect rare genetic mutations, which may be prese...
Source: Medgadget - Category: Medical Devices Authors: Ben Ouyang Tags: Genetics Medicine Source Type: blogs
More News: Cancer | Cancer & Oncology | China Health | Clinical Trials | Funding | Genetics | Harvard | Medical Devices